View Author
study patient genotype statin ace inhibitors inhibitor polymorphism interaction treatment control antagonist statin treatment antihypertensive i antagonists variant result index date allele utrecht signi effect carrier month pharmacogenetic response record pharmacy disease signi ficant interaction netherland index subject pharmacy records therapy vkorc system angiotensin phenprocoumon cholesterol participant university antihypertensive drugs ficant infarction maitland-van der zee agtr 1 association hvh study health level maitland-van table vkorc 1 illumina bene fit population scarb difference factor enzyme heart cyp 2c article group hypertension prescription research statin responsiveness ucp study effectiveness analysis pcsk 9 gene cyp 2c genotypes genotype data acenocoumarol reference ischaemic heart disease pharmo diabetes mellitus hypercholesterolemic
3 Most Recent Publications
|
Long-term anticoagulant effects of CYP2C9 and VKORC1 genotypes in phenprocoumon users
(Article)
Verhoef, T.I. Orlewska, E. Hegazy, H. Boer, A. de Maitland-van der Zee, A-H. |
2012-12-01
|
|
Genetic variation in the renin-angiotensin system, use of renin-angiotensin system inhibitors and the risk of myocardial infarction
(Article)
Maitland-van der Zee, A-H. Wieren-de Wijer, D.B.M.A. van Klungel, O.H. Boer, A. de Kroon, A.A. Leeuw, P.W. de Schiffers, P. Janssen, R.G.J.H. Psaty, B.M. Tikka-Kleemola, P. Stricker, B.H.Ch. |
2011-09-01
|
|
Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI
(Article)
Peters, B.J.M. Pett, H. Klungel, O.H. Stricker, B.H.Ch. Psaty, B.M. Glazer, N.L. Wiggins, K.L. Bis, J.C. Boer, A. de Maitland-van der Zee, A-H. |
2011-08-01
|